Pscilly

Reviews of LPH-48 – Short-duration 5-HT2A agonist fast-follower

No reviews yet. Share the first one.

LPH-48 – Short-duration 5-HT2A agonist fast-follower by Lophora ApS

Investigational preclinical candidate for CNS and psychiatric disorders; a specific indication has not been disclosed. It is in preclinical development. Investigational; not for sale.

Guides about LPH-48 – Short-duration 5-HT2A agonist fast-follower

Related news

More from Lophora ApS